ArticleIn silico pharmacology2025

Pharmacophoric analogs of Savolitinib reveal promising inhibitors of the c-MET receptor tyrosine kinase for drug discovery: in silico investigation.

Lateef Adegboyega Sulaimon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.